Healthcare Innovation in the 21st Century: Sponsors:  Co-Hosted By:  Join a panel discussion with Deputy Secretary of the HHS Tevi D. Troy, Ph.D., and senior officials from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services (CMS), and the Agency for Healthcare Research and Quality (AHRQ) to highlight the work taking place in and between their respective agencies to facilitate the development of innovative medical technologies. Wednesday, December 10, 2008 To register, please email Kathryn Bailey at kbailey@baybio.org or For more information please visit www.baybio.org Agenda Welcoming Remarks Regis B. Kelly, Ph.D. Director, The California Institute for Quantitative Biosciences Opening Remarks and Introduction of Deputy Secretary Tevi Troy Matthew M. Gardner President and CEO, BayBio Promoting and Facilitating Innovation: HHS’ Dynamic Role Tevi D. Troy, Ph.D. Deputy Secretary, U.S. Department of Health and Human Services NIH: Investing in Innovation Alan Guttmacher, M.D. Acting Director, National Human Genome Research Institute National Institutes of Health FDA: Paving the Pathway for Innovation Frank Torti, M.D., M.P.H. Principal Deputy Commissioner and first Chief Scientist Food and Drug Administration CMS: Funding the Innovators of Today and Tomorrow Herb Kuhn Deputy Administrator and Acting Director, Center for Medicaid and State OperationsCenters for Medicare and Medicaid Services (Tentative) AHRQ: Helping Organizations Innovate and Adopt New Ideas Jean Slutsky, M.S.P.H. Director, Center for Outcomes Evidence (Tentative |